Archive for Month: September

Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients primary care records in situ using OpenSAFELY

Background

The COVID-19 pandemic affected how care was delivered to vulnerable patients, such as those with dementia or learning disability.

Objective

To explore whether this affected antipsychotic prescribing in at-risk populations.

Methods

With the approval of NHS England, we completed a retrospective cohort study,...

Read More